ArticleHuman gene therapy2015

Prevalence of anti-adeno-associated virus serotype 8 neutralizing antibodies and arylsulfatase B cross-reactive immunologic material in mucopolysaccharidosis VI patient candidates for a gene therapy trial.

Rita Ferla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.